Indication
Serratia osteomyelitis
Serratia osteomyelitis is an uncommon, invasive bacterial infection of the bone and bone marrow caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens*. Read more about Serratia osteomyelitis
81 drugs 59 manufacturers
Drugs that treat it
Common Serratia osteomyelitis therapies.
CIPROFLOXACIN HCL
AMIKACIN SULFATE
CIPROFLOXACIN
AMIKACIN SULFATE
CIPROFLOXACIN (ciprofloxacin lactate)
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSerratia osteomyelitis is an uncommon, invasive bacterial infection of the bone and bone marrow caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens*.
The condition primarily affects immunocompromised individuals, patients with healthcare-associated exposures or indwelling instrumentation, people who inject drugs, and individuals who have sustained open trauma or surgical contamination.
Pathophysiologically, the organism establishes inflammatory destruction within cortical bone and the medullary canal via hematogenous seeding—frequently targeting the axial skeleton, such as the vertebrae—or by contiguous spread from adjacent soft tissue.
Defining clinical features include localized bone pain, erythema, swelling, tenderness, low-grade fevers, and radiographic evidence of osteolysis, periosteal reaction, or abscess formation.
- nih.gov
Serratia osteomyelitis is an uncommon, invasive bacterial infection of the bone and bone marrow caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens* Pathophysiologically, the organism establishes inflammatory destruction within cortical bone and the medullary canal via hematogenous seeding—frequently targeting the axial skeleton, such as the vertebrae—or by contiguous spread from adjacent soft tissue
- nih.gov
Serratia osteomyelitis is an uncommon, invasive bacterial infection of the bone and bone marrow caused by species of the Gram-negative opportunistic bacillus *Serratia*, most frequently *Serratia marcescens* The condition primarily affects immunocompromised individuals, patients with healthcare-associated exposures or indwelling instrumentation, people who inject drugs, and individuals who have sustained open trauma or surgical contamination
- nih.gov
The condition primarily affects immunocompromised individuals, patients with healthcare-associated exposures or indwelling instrumentation, people who inject drugs, and individuals who have sustained open trauma or surgical contamination Pathophysiologically, the organism establishes inflammatory destruction within cortical bone and the medullary canal via hematogenous seeding—frequently targeting the axial skeleton, such as the vertebrae—or by contiguous spread from adjacent soft tissue Definin...
- nih.gov
The condition primarily affects immunocompromised individuals, patients with healthcare-associated exposures or indwelling instrumentation, people who inject drugs, and individuals who have sustained open trauma or surgical contamination
- nih.gov
Pathophysiologically, the organism establishes inflammatory destruction within cortical bone and the medullary canal via hematogenous seeding—frequently targeting the axial skeleton, such as the vertebrae—or by contiguous spread from adjacent soft tissue Defining clinical features include localized bone pain, erythema, swelling, tenderness, low-grade fevers, and radiographic evidence of osteolysis, periosteal reaction, or abscess formation
- nih.gov
Defining clinical features include localized bone pain, erythema, swelling, tenderness, low-grade fevers, and radiographic evidence of osteolysis, periosteal reaction, or abscess formation
Personalize your experience
Follow Serratia osteomyelitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.